Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 11331083)

Published in Biol Psychiatry on May 01, 2001

Authors

A C Chen1, Y Shirayama, K H Shin, R L Neve, R S Duman

Author Affiliations

1: Department of Psychiatry, Division of Molecular Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, New Haven 06508, USA.

Articles citing this

Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature (2011) 5.17

Dynorphin, stress, and depression. Brain Res (2009) 2.45

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A (2007) 2.22

CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits. Nat Neurosci (2009) 2.11

Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry (2007) 2.01

Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology (2010) 1.87

Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology (2010) 1.81

The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry (2010) 1.80

The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology (2011) 1.52

Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens. Biol Psychiatry (2010) 1.41

Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci (2007) 1.30

Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.29

Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19

Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology (2008) 1.19

Role of nuclear factor kappaB in ovarian hormone-mediated stress hypersensitivity in female mice. Biol Psychiatry (2009) 1.17

DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness. ACS Chem Neurosci (2011) 1.13

Molecular and genetic substrates linking stress and addiction. Brain Res (2009) 1.11

Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx (2005) 1.10

Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent. Hippocampus (2009) 1.09

Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci (2006) 1.06

A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation. Biol Psychiatry (2008) 1.06

The underlying neurobiology of bipolar disorder. World Psychiatry (2003) 1.05

CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure. Biol Psychiatry (2007) 1.01

Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviors. J Neurosci (2009) 0.99

Neuropeptides in depression: role of VGF. Behav Brain Res (2008) 0.97

Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural Plast (2013) 0.96

Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol (2011) 0.96

Sex differences in the effects of acute and chronic stress and recovery after long-term stress on stress-related brain regions of rats. Cereb Cortex (2008) 0.94

Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr Dis Treat (2008) 0.94

Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol (2009) 0.89

Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology (2013) 0.89

Lesions of the basolateral amygdala reverse the long-lasting interference with shuttle box escape produced by uncontrollable stress. Behav Brain Res (2010) 0.86

Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator τ. J Neurosci (2013) 0.85

Treadmill exercise alleviates stress-induced impairment of social interaction through 5-hydroxytryptamine 1A receptor activation in rats. J Exerc Rehabil (2015) 0.85

Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depression. Biol Psychiatry (2011) 0.84

Neural plasticity: consequences of stress and actions of antidepressant treatment. Dialogues Clin Neurosci (2004) 0.82

MicroRNA as therapeutic targets for treatment of depression. Neuropsychiatr Dis Treat (2013) 0.81

Cellular plasticity and resilience and the pathophysiology of severe mood disorders. Dialogues Clin Neurosci (2004) 0.81

Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis. FASEB J (2014) 0.81

The nuclear transcription factor CREB: involvement in addiction, deletion models and looking forward. Curr Neuropharmacol (2007) 0.80

Association study of CREB1 with Major Depressive Disorder and related phenotypes. Am J Med Genet B Neuropsychiatr Genet (2009) 0.80

TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation. Transl Psychiatry (2016) 0.79

Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. Depress Anxiety (2016) 0.78

Neuropsychophysiological correlates of depression. Ind Psychiatry J (2010) 0.77

Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment. Mol Psychiatry (2015) 0.77

Tetramethylpyrazine Produces Antidepressant-Like Effects in Mice Through Promotion of BDNF Signaling Pathway. Int J Neuropsychopharmacol (2015) 0.77

Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. Transl Psychiatry (2016) 0.77

Drug withdrawal conceptualized as a stressor. Behav Pharmacol (2014) 0.77

Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test. J Neural Transm (Vienna) (2008) 0.77

The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder. Genet Test Mol Biomarkers (2012) 0.77

Viral vector induction of CREB expression in the periaqueductal gray induces a predator stress-like pattern of changes in pCREB expression, neuroplasticity, and anxiety in rodents. Neural Plast (2009) 0.76

[New insights into the pathogenesis and pathophysiology of depression]. Nervenarzt (2007) 0.76

Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression. Am J Med Genet B Neuropsychiatr Genet (2016) 0.75

Reward Network Immediate Early Gene Expression in Mood Disorders. Front Behav Neurosci (2017) 0.75

The Antidepressant-like Effects of Estrogen-mediated Ghrelin. Curr Neuropharmacol (2015) 0.75

Icariin upregulates phosphorylated cyclic adenosine monophosphate response element binding protein levels in the hippocampus of the senescence- accelerated mouse. Neural Regen Res (2012) 0.75

Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway. Br J Pharmacol (2016) 0.75

A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75

Articles by these authors

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci (1995) 5.10

Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature (1988) 4.83

Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29

Regulation of cocaine reward by CREB. Science (1998) 4.07

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science (1989) 3.47

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci (1996) 3.33

EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell (2001) 3.20

Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci (2001) 3.09

Quantitative calibration and use of DNA probes for investigating chromosome abnormalities in the Prader-Willi syndrome. Am J Med Genet (1989) 2.83

Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res (1986) 2.77

Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res (2001) 2.77

Developmentally regulated expression of specific tau sequences. Neuron (1989) 2.62

Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61

Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry (2008) 2.42

Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala. J Neurosci (2001) 2.30

The microtubule binding domain of tau protein. Neuron (1989) 2.17

MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci U S A (1993) 2.07

Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer. Ann Oncol (2008) 2.03

The primary structure and analysis of the squid kinesin heavy chain. J Biol Chem (1990) 2.02

Construction and characterization of E. coli promoter-probe plasmid vectors. I. Cloning of promoter-containing DNA fragments. Gene (1979) 1.87

cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci (2000) 1.86

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys (1991) 1.77

Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet (1993) 1.72

A somatic cell hybrid with a single human chromosome 22 corrects the defect in the CHO mutant (Ade-I) lacking adenylosuccinase activity. Cytogenet Cell Genet (1987) 1.68

Sensitization to morphine induced by viral-mediated gene transfer. Science (1997) 1.62

Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinaldehyde-specific dehydrogenase. Eur J Biochem (1996) 1.59

Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol (1998) 1.58

The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature (1987) 1.57

The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem (2000) 1.52

APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J Biol Chem (1996) 1.46

Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci U S A (1988) 1.45

The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects. Exp Neurol (1989) 1.45

Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci (2002) 1.44

Radiation and chemotherapy improve outcome in oligodendroglioma. Int J Radiat Oncol Biol Phys (1997) 1.40

Immunoscintigraphy in the detection of tuberculosis with radiolabelled antibody fragment against Mycobacterium bovis bacillus Calmette-Guérin: a preliminary study in a rabbit model. Eur J Nucl Med (1992) 1.39

The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science (1987) 1.35

Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol (1991) 1.34

Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem (1990) 1.32

Alveolar soft part sarcoma: MR and angiographic findings. Skeletal Radiol (2000) 1.32

Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res (2003) 1.31

Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res (2000) 1.29

Human chromosome 21-encoded cDNA clones. Gene (1986) 1.29

Identification of a somatodendritic targeting signal in the cytoplasmic domain of the transferrin receptor. J Neurosci (1997) 1.28

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol (1990) 1.28

Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus vector expressing GluR1. J Neurosci (2000) 1.28

Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse (1995) 1.27

Repeated stress increases catalytic TrkB mRNA in rat hippocampus. Neurosci Lett (1999) 1.27

Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci (1996) 1.25

Overexpression of HuD accelerates neurite outgrowth and increases GAP-43 mRNA expression in cortical neurons and retinoic acid-induced embryonic stem cells in vitro. Exp Neurol (2001) 1.25

Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci (1998) 1.24

Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol (2000) 1.24

Minimizing artifacts caused by metallic implants at MR imaging: experimental and clinical studies. AJR Am J Roentgenol (1998) 1.22

Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull (2001) 1.22

Overexpression of HuD, but not of its truncated form HuD I+II, promotes GAP-43 gene expression and neurite outgrowth in PC12 cells in the absence of nerve growth factor. J Neurochem (2000) 1.21

Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci U S A (1996) 1.19

beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci U S A (1993) 1.19

5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci (1997) 1.19

Depresssion--emerging insights from neurobiology. Br Med Bull (2001) 1.18

Transfection of PC12 cells with the human GAP-43 gene: effects on neurite outgrowth and regeneration. Brain Res Mol Brain Res (1990) 1.18

Eukaryotic DNA fragments which act as promoters for a plasmid gene. Nature (1979) 1.16

A C-terminal, calmodulin-like regulatory domain from the plasma membrane Ca2+-pumping ATPase. Proc Natl Acad Sci U S A (1988) 1.15

The BAM H1 restriction site in the bacteriophage T4 chromosome is located in or near gene 8. Genetics (1979) 1.15

Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience (1999) 1.14

Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene (1994) 1.14

Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors. J Neurochem (1992) 1.13

Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys (1997) 1.12

Inactivation of the p53 gene by either mutation or HPV infection is extremely frequent in human oral squamous cell carcinoma cell lines. Eur J Cancer B Oral Oncol (1994) 1.12

Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol (1996) 1.11

Expression and heteromeric interactions of non-N-methyl-D-aspartate glutamate receptor subunits in the developing and adult cerebellum. Neuroscience (1998) 1.11

Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci (1999) 1.10

The Seoul Metropolitan Preschool Vision Screening Programme: results from South Korea. Br J Ophthalmol (2004) 1.10

The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. Genomics (1989) 1.10

Rat LCR1: cloning and cellular distribution of a putative chemokine receptor in brain. Mol Psychiatry (1996) 1.09

Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci U S A (1992) 1.09

Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J Neurochem (1989) 1.07

An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem (1997) 1.07

Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol (1997) 1.07

Therapeutic response of breast carcinoma monitored by 31P MRS in situ. Magn Reson Med (1989) 1.06

Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J Neurosci (2012) 1.06

Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J Neurochem (1994) 1.06

Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res Mol Brain Res (1999) 1.06

Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci U S A (1991) 1.04

Analysis of the tissue-specific distribution of mRNAs encoding the plasma membrane calcium-pumping ATPases and characterization of an alternately spliced form of PMCA4 at the cDNA and genomic levels. J Biol Chem (1992) 1.03

Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J Pharmacol Exp Ther (1996) 1.02

Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment. Ann Neurol (1989) 1.02

Sequence and expression of a neuropeptide Y receptor cDNA. Mol Pharmacol (1991) 1.01

Post-transcriptional regulation of the GAP-43 gene by specific sequences in the 3' untranslated region of the mRNA. J Neurosci (1997) 1.01

beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Brain Res Mol Brain Res (2001) 1.01

Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J Neurochem (1992) 1.01

Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) (2001) 1.01

Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med (2001) 1.00

Chronic ethanol administration regulates the expression of GABAA receptor alpha 1 and alpha 5 subunits in the ventral tegmental area and hippocampus. J Neurochem (1997) 1.00

MR appearance of distal femoral cortical irregularity (cortical desmoid). J Comput Assist Tomogr (1996) 0.99

Region-specific regulation of RGS4 (Regulator of G-protein-signaling protein type 4) in brain by stress and glucocorticoids: in vivo and in vitro studies. J Neurosci (1999) 0.99